If youve been prescribed Wegovy ( semaglutide ) and you have insurance through Aetna, youre probably wondering if your plan includes coverage for Wegovy
GLP-1 medications in the context of Hashimoto disease require careful thyroid monitoring, because the metabolic effects of suboptimal thyroid function can completely neutralize the caloric deficit that GLP-1 therapy creates
Injection Site Reactions: Many GLP-1 medications are administered via subcutaneous injection, which can lead to injection site reactions such as redness, itching, or swelling
Incidence of severe hypoglycemia was 1% b Hypoglycemia was more frequent when RYBELSUS was used in combination with insulin secretagogues (eg, sulfonylurea) or insulin - Patients may require a lower dose of the secretagogue or insulin to reduce the risk of hypoglycemia in this setting A cardiovascular outcomes trial (CVOT) compared RYBELSUS added to standard of care vs placebo added to standard of care Primary endpoint was the time to first occurrence of a 3-part composite outcome of major adverse cardiovascular events (MACE), which included cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke The total number of primary component MACE endpoints was 137 (61 [3.8%] with RYBELSUS and 76 [4.8%] with placebo) CV=cardiovascular
[Ca 2+ ] i imaging videos were analysed using the Fiji imaging processing package